About CytRx Corp.

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.47$ per share.

The book value per share is 0.75$

CytRx Corp. website

Create a solid portfolio with CYTR

Add CYTR to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -15M - -15M -0.47 - - 30M 0.75 -15M - -15M